Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M610672200 on April 16, 2007

J. Biol. Chem., Vol. 282, Issue 24, 17450-17459, June 15, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/24/17450    most recent
M610672200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlaepfer, D. D.
Right arrow Articles by Mitra, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlaepfer, D. D.
Right arrow Articles by Mitra, S. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tumor Necrosis Factor-{alpha} Stimulates Focal Adhesion Kinase Activity Required for Mitogen-activated Kinase-associated Interleukin 6 Expression*

David D. Schlaepfer1, Shihe Hou, Ssang-Taek Lim, Alok Tomar, Honggang Yu, Yangmi Lim, Dan A. Hanson, Sean A. Uryu, John Molina, and Satyajit K. Mitra

From the Department of Immunology, The Scripps Research Institute, La Jolla, California 92037

Focal adhesion kinase (FAK) is a cytoplasmic protein-tyrosine kinase that promotes cell migration, survival, and gene expression. Here we show that FAK signaling is important for tumor necrosis factor-{alpha} (TNF{alpha})-induced interleukin 6 (IL-6) mRNA and protein expression in breast (4T1), lung (A549), prostate (PC-3), and neural (NB-8) tumor cells by FAK short hairpin RNA knockdown and by comparisons of FAK-null (FAK–/–) and FAK+/+ mouse embryo fibroblasts. FAK promoted TNF{alpha}-stimulated MAPK activation needed for maximal IL-6 production. FAK was not required for TNF{alpha}-mediated nuclear factor-{kappa}B or c-Jun N-terminal kinase activation. TNF{alpha}-stimulated FAK catalytic activation and IL-6 production were inhibited by FAK N-terminal but not FAK C-terminal domain overexpression. Analysis of FAK–/– fibroblasts stably reconstituted with wild type or various FAK point mutants showed that FAK catalytic activity, Tyr-397 phosphorylation, and the Pro-712/713 proline-rich region of FAK were required for TNF{alpha}-stimulated MAPK activation and IL-6 production. Constitutively activated MAPK kinase-1 (MEK1) expression in FAK–/– and A549 FAK short hairpin RNA-expressing cells rescued TNF{alpha}-stimulated IL-6 production. Inhibition of Src protein-tyrosine kinase activity or mutation of Src phosphorylation sites on FAK (Tyr-861 or Tyr-925) did not affect TNF{alpha}-stimulated IL-6 expression. Moreover, analyses of Src–/–, Yes–/–, and Fyn–/– fibroblasts showed that Src expression was inhibitory to TNF{alpha}-stimulated IL-6 production. These studies provide evidence for a novel Src-independent FAK to MAPK signaling pathway regulating IL-6 expression with potential importance to inflammation and tumor progression.


Received for publication, November 17, 2006 , and in revised form, March 30, 2007.

* This work was supported in part by CA102310 [GenBank] and CA87038 from the National Institutes of Health. This is manuscript 18575-IMM from The Scripps Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported in part by National Institutes of Health Grant CA75240 and American Heart Association Established Investigator Award 0540115N. To whom correspondence should be addressed: The Scripps Research Institute, Dept. of Immunology, IMM 21, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-784-8207; Fax: 858-784-8289; E-mail: dschlaep{at}scripps.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. A. Kiely, G. S. Baillie, R. Barrett, D. A. Buckley, D. R. Adams, M. D. Houslay, and R. O'Connor
Phosphorylation of RACK1 on Tyrosine 52 by c-Abl Is Required for Insulin-like Growth Factor I-mediated Regulation of Focal Adhesion Kinase
J. Biol. Chem., July 24, 2009; 284(30): 20263 - 20274.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Tomar, S.-T. Lim, Y. Lim, and D. D. Schlaepfer
A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells
J. Cell Sci., June 1, 2009; 122(11): 1852 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Behmoaram, K. Bijian, S. Jie, Y. Xu, A. Darnel, T. A. Bismar, and M. A. Alaoui-Jamali
Focal Adhesion Kinase-Related Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Co-Overexpressed in Early-Stage and Invasive ErbB-2-Positive Breast Cancer and Cooperate for Breast Cancer Cell Tumorigenesis and Invasiveness
Am. J. Pathol., November 1, 2008; 173(5): 1540 - 1550.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. M. Weis, S.-T. Lim, K. M. Lutu-Fuga, L. A. Barnes, X. L. Chen, J. R. Gothert, T.-L. Shen, J.-L. Guan, D. D. Schlaepfer, and D. A. Cheresh
Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK
J. Cell Biol., April 3, 2008; 181(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Semaan, G. Alsaleh, J.-E. Gottenberg, D. Wachsmann, and J. Sibilia
Etk/BMX, a Btk Family Tyrosine Kinase, and Mal Contribute to the Cross-Talk between MyD88 and FAK Pathways
J. Immunol., March 1, 2008; 180(5): 3485 - 3491.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement